Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Dr. Gillis' Wellness Center vs PauseRX

Dr. Gillis' Wellness Center
Graded #177

Lower grade

vs+1.5
PauseRX
Graded #149

Higher grade

The verdict

PauseRX takes it — 68.5/100 to 67/100, but only just.

PauseRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PauseRX is a nationwide compounded GLP-1 telehealth platform notable for its transparency: it names its 503A pharmacy partner (Strive Pharmacy in Gilbert, AZ), its physician network (Beluga Health), and… Dr. Gillis' Wellness Center is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePauseRX +2
64
66
Dose & formulationPauseRX +17
68
85
Clinical oversightDr. Gillis' Wellness Center +1
84
83
Labs & monitoringDr. Gillis' Wellness Center +1
53
52
FulfillmentDr. Gillis' Wellness Center +20
81
61
Contract termsPauseRX +4
37
41
Dr. Gillis' Wellness Center · left barPauseRX · right bar

The numbers

MetricDr. Gillis' Wellness CenterPauseRX
WeighScore67/10068.5/100
GradeCC
Scorecard rank#177#149
Semaglutide$149/mo (starting dose, compounded)$199/mo
TirzepatideNot disclosed$249/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only

Strengths

  • Sublingual ODT tablets offered as needle-free alternative
  • Broad GLP-1 menu: semaglutide, tirzepatide, and retatrutide
  • Transparent pricing: $150 starting dose, plans from $149/mo
  • Led by board-certified physician/surgeon with 25+ years experience
  • No contracts; flexible weekly, bi-weekly, or monthly cadence

Where it loses points

  • Specific dose-tier pricing beyond starting plan not detailed
  • Compounded vs brand not explicitly stated for all meds
  • Smaller clinic vs national telehealth brands
  • State licensing list not published
PauseRX

Graded #149 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard